ConductScience.org, home

Paper33649263

Standard and modified techniques for parenchyma-preserving hepatectomy focused on segments I+IV resection in patients with perihilar cholangiocarcinoma.

Hwang S. Ann Hepatobiliary Pancreat Surg, 2021. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Standard and modified techniques for parenchyma-preserving hepatectomy focused on segments I+IV resection in patients with perihilar cholangiocarcinoma. Papers, record 33649263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33649263

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Standard and modified techniques for parenchyma-preserving hepatectomy focused on segments I+IV resection in patients with perihilar cholangiocarcinoma.
PubMed
Journal
Ann Hepatobiliary Pancreat Surg
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.52
iCite
Revised in PubMed
2024-03-31
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hwang SShinhttps://orcid.org/0000-0002-9045-2531

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119705374Extent of liver resection for hilar cholangiocarcinoma.Br J Surg2009https://conductscience.org/library/papers/19705374PubMed
29481397Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection?Surgery1998https://conductscience.org/library/papers/9481397PubMed
38199989Invasive growth patterns of hepatic hilar ductal carcinoma. A histologic analysis of 18 surgical cases.Cancer1994https://conductscience.org/library/papers/8199989PubMed
48665234Radical surgery for advanced gallbladder carcinoma.Br J Surg1996https://conductscience.org/library/papers/8665234PubMed
53945893Surgical treatment of hilar carcinoma of the bile duct.Surg Gynecol Obstet1986https://conductscience.org/library/papers/3945893PubMed
627384172Preoperative Left Portal Vein Embolization for Left Liver Resection in High-Risk Hepatobiliary Malignancy Patients.World J Surg2016https://conductscience.org/library/papers/27384172PubMed
73621131The long-term survival of patients with carcinoma of the main hepatic duct junction.Cancer1987https://conductscience.org/library/papers/3621131PubMed
826304608Preoperative Sequential Portal and Hepatic Vein Embolization in Patients with Hepatobiliary Malignancy.World J Surg2015https://conductscience.org/library/papers/26304608PubMed
934402446Parenchyma-preserving hepatectomy including segments I + IV resection and bile duct resection in a patient with type IV perihilar cholangiocarcinoma: A case report with video clip.Ann Hepatobiliary Pancreat Surg2021https://conductscience.org/library/papers/34402446PubMed
1019851704Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.J Hepatobiliary Pancreat Sci2010https://conductscience.org/library/papers/19851704PubMed
1115754098How I do it: assessment of hepatic functional reserve for indication of hepatic resection.J Hepatobiliary Pancreat Surg2005https://conductscience.org/library/papers/15754098PubMed
122396193Carcinoma of the main hepatic duct junction: indications, operative morbidity and mortality, and long-term survival.Surgery1990https://conductscience.org/library/papers/2396193PubMed
137683844Aggressive surgical therapy for Klatskin tumors.Am J Surg1993https://conductscience.org/library/papers/7683844PubMed
148988723What constitutes long-term survival after surgery for hilar cholangiocarcinoma?Cancer1997https://conductscience.org/library/papers/8988723PubMed
156197596Surgical approaches to cholangiocarcinoma at confluence of hepatic ducts.Lancet1984https://conductscience.org/library/papers/6197596PubMed
168380975Improvements in survival by aggressive resections of hilar cholangiocarcinoma.Ann Surg1993https://conductscience.org/library/papers/8380975PubMed
1710482688S4a + S5 with caudate lobe (S1) resection using the Taj Mahal liver parenchymal resection for carcinoma of the biliary tract.J Gastrointest Surg1999https://conductscience.org/library/papers/10482688PubMed
182166381Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus.World J Surg1990https://conductscience.org/library/papers/2166381PubMed
1925947549Quantified Risk Assessment for Major Hepatectomy via the Indocyanine Green Clearance Rate and Liver Volumetry Combined with Standard Liver Volume.J Gastrointest Surg2015https://conductscience.org/library/papers/25947549PubMed
2010589594Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma.J Am Coll Surg1999https://conductscience.org/library/papers/10589594PubMed

See all 21 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
41922858Robotic-Modified Taj Mahal Hepatectomy for Type IV Hilar Cholangiocarcinoma.Ann Surg Oncol2026https://conductscience.org/library/papers/41922858PubMed
34845131Intraductal tubulopapillary neoplasms of the pancreas and biliary tract: The black swan of hepatobiliary surgery.Ann Hepatobiliary Pancreat Surg2021https://conductscience.org/library/papers/34845131PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33649263

GET https://conductscience.org/api/papers/v1/33649263/references?page=2